Blog
CEA tumor marker: a brief explanatory guide
What is the CEA tumor marker?
The tumor marker CEA (carcinoembryonic antigen or CEA) is a specific protein that is normally produced in the fetus during development. In adults, its level in the blood is very low or absent. An increase in CEA in an adult may indicate oncological processes or chronic inflammation.
The CEA tumor marker is not a «cancer indicator» in the narrow sense — it can be elevated in various diseases, not only malignant ones, but it is often used for:
monitoring effectiveness of cancer treatment
detection of relapses after surgical or chemotherapy treatment
tumor progression assessments in the intestines, lungs, mammary gland
When is a CEA test prescribed?
If rectal or colon cancer is suspected
In patients with lung, stomach, breast, pancreatic cancer
After surgery to remove the tumor - to monitor for recurrence
Together with other markers - for a comprehensive assessment of the condition
Norm and deviation
In healthy people, the level of CEA in the blood is usually:
0–3 ng/mL in non-smokers
0–5 ng/mL in smokers (smoking increases the level of the marker)
An increase in the level above normal may indicate:
Oncological diseases:
– cancer of the colon, stomach, pancreas
– lung, ovarian, breast cancer
Non-oncological conditions:
– cirrhosis of the liver
– chronic bronchitis
– pancreatitis
– peptic ulcer
Table: REA levels and possible interpretations
| CEA level (ng/ml) | Possible interpretation |
|---|---|
| 0–3 | Non-smoking rate |
| 3–5 | Norm for smokers, borderline level |
| 5–10 | Possible chronic inflammation or benign changes |
| >10 | Suspicion of a tumor process, diagnosis required |
| >20–30 | Often indicates widespread cancer or metastases |
Important nuances
Only one REA not used for diagnosis.
Increasing REA levels does not always mean cancer — additional examination methods are required (CT scan, colonoscopy, biopsy).
The marker level can be reduced after treatment — this is a good prognostic sign.
Gradual increase in CEA after surgery may signal a relapse.
References to sources
Mayo Clinic. CEA test
National Cancer Institute (USA). Biomarker testing guidelines
WHO - Global Cancer Observatory
The CEA test is a monitoring tool, not a verdict. It helps doctors monitor the dynamics of the disease and the results of treatment, but it does not replace a full diagnosis.
